LGC, an international science-based company and recognised market leader in forensic and diagnostic services and reference materials, today announced that it has signed an agreement with Psychemedics Corporation, the world's largest provider of drug testing using hair analysis, to market the patented Psychemedics hair analysis drug test in the UK and Europe. 

Psychemedics Corporation has been the pioneer and leader in testing for drugs of abuse using hair analysis since 1987. Thousands of corporate clients from a wide variety and cross section of domestic and international business rely on Psychemedics' patented hair analysis test. In addition, some of the largest police forces such as New York City Police Department, Chicago Police Department, San Francisco Police Department and many others, as well as Federal Reserve Banks are also Psychemedics clients. 

LGC has almost 100 years' experience of forensic work, from crime scene to the court room and through LGC Forensics, a major division of the LGC Group, it is the UK's largest, full-service independent forensic service provider. LGC Forensics mobilises considerable and highly specialised resources to discover, analyse and present reliable forensic evidence on behalf of law enforcement agencies, legal professionals and private individuals. Hair drug testing is among the full range of services on offer from LGC Forensics and is a vital tool in identifying drugs of abuse and drug users. 

Steve Allen, Managing Director of LGC Forensics, commented: "This important tool expands our current drug testing services to our UK and European clients. LGC Forensics has an excellent reputation for providing high quality drug testing services. We are extremely pleased to be able provide the Psychemedics patented hair test which has been the quality standard in hair testing since 1987." 

Raymond C. Kubacki, Chairman and Chief Executive Officer of Psychemedics, stated: "We are very proud to be working with LGC, a company whose forensic science capability sets the highest quality standards in the UK. Since we provide the highest quality and most cost effective drug test available, this is a perfect match. With this agreement, we hope to capitalise on the rapidly developing growth opportunities in the UK and Europe, and help companies establish and maintain a drug free workplace."

For further information please visit www.lgc.co.uk